• A Case of Eosinophilia Myalgia Syndrome: Imaging Features of a Unique and Rare Entity
• A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation
• Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations
• Acute Exacerbation of Hypereosinophilic Syndrome Complicated With Dermatitis, Enteritis, and Myositis: A Case Report
• Acute interstitial pneumonia: diagnostic approach and management
• Acute painful paraplegia in a 49-year-old man with allergic asthma
• Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake
• AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome?
• Application of multi-slice spiral CT in the diagnosis of pulmonary hypertension
• Association of eosinophilic fasciitis with morphea
• Atypical presentation of atypical haemolytic uraemic syndrome
• B-cell acute lymphoblastic leukemia associated with hypereosinophilia: a case report and brief literature review
• Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2004. A 68-year-old man with end-stage renal disease and thickening of the skin
• Cerebral Infarction and Myalgia in a 75-year-old Man with Eosinophilic Granulomatosis with Polyangiitis
• Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis
• Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation
• Churg-Strauss Syndrome following PTU Treatment
• Churg-Strauss syndrome presenting as myositis following unaccustomed exercise
• Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats
• Clinical & biochemical profile of trichinellosis outbreak in north India
• Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases
• Current differential diagnosis of hypereosinophilic syndrome
• Diagnosis and classification of eosinophilic fasciitis
• Diagnostic performance of echocardiography in the follow-up of patients with toxic oil syndrome
• Diagnostic problems in eosinophilic fasciitis
• Does 5-hydroxytryptophan cause acute and chronic toxic perturbations in rats?
• Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia
• Drug-induced eosinophilic lung disease
• Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma
• Effects and side effects associated with the non-nutritional use of tryptophan by humans
• Environmental- and injury-related epidemic-assistance investigations, 1946-2005
• Eosinophilia in Rheumatologic/Vascular Disorders
• Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil
• Eosinophilia-myalgia syndrome induced by excessive L-tryptophan intake from cashew nuts
• Eosinophilia-myalgia syndrome presenting with overlapping features of eosinophilic fasciitis and sarcoidal granulomas
• Eosinophilic fasciitis
• Eosinophilic fasciitis (Shulman disease)
• Eosinophilic fasciitis (Shulman's disease): a case series of 11 patients
• Eosinophilic fasciitis (Shulman's disease): Diagnostic and therapeutic review
• Eosinophilic fasciitis associated with myositis: Report of four cases and review of the literature
• Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis
• Eosinophilic myositis in calpainopathy: could immunosuppression of the eosinophilic myositis alter the early natural course of the dystrophic disease?
• Eosinophilic perimyositis as the presenting feature of a monoclonal T-cell expansion
• Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma
• Food contamination
• Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome
• Hypereosinophilic syndrome and other rheumatic diseases with hypereosinophilia
• Hypereosinophilic syndrome developing after prednisolone therapy for autoimmune hemolytic anemia
• Idiopathic eosinophilic cholecystitis with cholelithiasis: a report of two cases
• Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms
• Immunohistochemical studies of the kynurenine pathway in morphea
• Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis?
• Katayama syndrome
• Leukemoid reaction secondary to hypersensitivity syndrome to phenobarbital: a case report
• Meglumine antimoniate-induced DRESS: original case with a positive skin test
• Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia
• Methimazole-induced myositis: a case report and review of the literature
• Miliary tuberculosis in a patient with eosinophilic fasciitis
• Muscle pain, fever, cough, and progressive dyspnea in a woman with eosinophilic pneumonia
• Myalgia and fever in a 35-year-old woman
• Neuromuscular disorders associated with apical hypertrophic cardiomyopathy
• Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia
• Not just eosinophilic fasciitis
• Opinion on the diagnosis and treatment of human trichinellosis
• Otolaryngologic manifestations of Churg-Strauss sindrome. Report of a case and review of the literature
• Panniculitis
• Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies
• Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome
• Pharmacovigilance and drug-induced rare diseases: Strengths of the French Network of Regional Pharmacovigilance Centres
• Pneumonia and seizures due to hypereosinophilic syndrome-organ damage and eosinophilia without synchronisation: A case report
• Possible Parkinson's Disease Induced by Chronic Manganese Supplement Ingestion
• Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan
• Prediction of drug-induced eosinophilia adverse effect by using SVM and naive Bayesian approaches
• Primary perineuritis, a rare but treatable neuropathy: Review of perineurial anatomy, clinicopathological features, and differential diagnosis
• Pulmonary hypertension as a result of drug therapy
• Review article toxic oil syndrome: review of immune aspects of the disease
• Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin
• Safety concerns regarding impurities in L-Tryptophan associated with eosinophilia myalgia syndrome
• Safety evaluation of dried L-tryptophan fermentation product in Sprague-Dawley rats
• Safety of 5-hydroxy-L-tryptophan
• Scleroderma-like disorders
• Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
• Serpiginous Purpuric Eruption of the Leg
• Severe eosinophilic syndrome associated with the use of probiotic supplements: a new entity?
• Shulman's syndrome (eosinophilic fasciitis)
• Simultaneous determination of L-tryptophan impurities in meat products
• Skin manifestations of toxic syndrome due to denatured rapeseed oil
• Strain-dependent acute lung injury after intra-tracheal administration of a 'refined' aniline-denatured rapeseed oil: a murine model of the toxic oil syndrome?
• Structural characterization of a case-implicated contaminant, "Peak X," in commercial preparations of 5-hydroxytryptophan
• Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome
• Successful extracorporeal liver dialysis for the treatment of trimethoprim-sulfamethoxazole-induced fulminant hepatic failure
• The first case of SARS-CoV-2-induced eosinophilic fasciitis
• The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline
• Toxic oil syndrome: survival in the whole cohort between 1981 and 1995
• Toxic oil syndrome: the perspective after 20 years
• Toxicology and safety study of L-tryptophan and its impurities for use in broiler feed
• Toxicology and safety study of L-tryptophan and its impurities for use in swine
• Two Catastrophes in One Patient: Drug Reaction with Eosinophilia and Systemic Symptoms and Toxic Shock Syndrome
• Vasculitis secondary to anti-C1q antibodies induced by Toxocariasis